Sumeet Bagadia names Sun Pharma, IndiGo and Infosys picks
In short
Sumeet Bagadia picked Sun Pharma, IndiGo and Infosys in a Mint Markets note. The summary said the Nifty 50 has not yet moved back above its 50-day EMA near 23,160, so he thinks the market upside is limited for now.
This matters to traders watching Dalal Street and these stocks. The note does not give the full target prices or stop-loss levels in the available reporting.
What the reporting says
Sumeet Bagadia named Sun Pharma, IndiGo and Infosys as his top stock recommendations in a Mint Markets summary. The publisher-supplied note said he sees the immediate upside on Dalal Street as capped because the Nifty 50 has not yet reclaimed its 50-day EMA near 23,160. The consequence is a cautious near-term market view, while no trade details beyond the cited target-price and stop-loss framing are provided.
Why it matters
Sumeet Bagadia highlighted Sun Pharma, IndiGo and Infosys in a Mint Markets stock-pick summary, while also saying the Nifty 50’s immediate upside looks capped until it reclaims its 50-day EMA near 23,160. That links the call to broader market sentiment on Dalal Street and to the three named stocks. The available reporting does not include the full recommendation details, such as exact targets or stop-loss levels.